Crestline Management, L.P. / SANA
Crestline Management, L.P.’s Sana Biotechnology Inc Position
Does Crestline Management, L.P. own Sana Biotechnology Inc (SANA)? Yes — 755.7K shares worth $2M (+4.70% of its 13F portfolio) as of Q1 2026, down from 1.22M shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
755.7K
% of Portfolio
+4.70%
Quarters Held
20
currently held
Position History SANA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 755.7K | $2M | +4.70% |
| Q4 2025 | 1.22M | $5M | +9.32% |
| Q3 2025 | 1.82M | $6M | +11.13% |
| Q2 2025 | 2.42M | $7M | +10.56% |
| Q1 2025 | 2.79M | $5M | +7.41% |
| Q4 2024 | 2.86M | $5M | +0.16% |
| Q3 2024 | 3.09M | $13M | +0.67% |
| Q2 2024 | 3.23M | $18M | +1.37% |
| Q1 2024 | 3.37M | $34M | +2.97% |
| Q4 2023 | 3.37M | $14M | +1.17% |
| Q3 2023 | 3.37M | $13M | +1.52% |
| Q2 2023 | 3.37M | $20M | +2.09% |
| Q1 2023 | 3.21M | $10M | +1.25% |
| Q4 2022 | 3.37M | $13M | +1.95% |
| Q3 2022 | 3.37M | $20M | +2.73% |
| Q2 2022 | 3.37M | $22M | +2.82% |
| Q1 2022 | 3.21M | $27M | +3.18% |
| Q4 2021 | 3.21M | $50M | +3.71% |
| Q3 2021 | 3.21M | $72M | +6.80% |
| Q2 2021 | 3.21M | $63M | +5.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Crestline Management, L.P.’s full portfolio or all institutional holders of SANA.